Truven Health Analytics Inc. - FORM 8-K - November 6, 2014

Attached files

file filename
EX-99.1 - EX-99.1 - Truven Health Analytics Inc.a14-23774_3ex99d1.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): November 6, 2014

 

Truven Holding Corp.

 

Truven Health Analytics Inc.

(Exact name of registrant parent guarantor as
specified in its charter)

 

(Exact name of registrant issuer as
specified in its charter)

 

Delaware

 

45-5164353

 

Delaware

 

06-1467923

(State or other
jurisdiction of
incorporation or
organization)

 

(I.R.S. Employer
Identification No.)

 

(State or other
jurisdiction of
incorporation or
organization)

 

(I.R.S. Employer
Identification No.)

 

777 E. Eisenhower Parkway

Ann Arbor, Michigan 48108

(734) 913-3000

(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

Item 8.01 Other Events.

 

On November 6, 2014, Truven Health Analytics Inc. (the “Company”) issued a press release announcing commencement of a private placement offering of $40 million aggregate principal amount of 10.625% Senior Notes due 2020. A copy of the press release is attached to this report as Exhibit 99.1 and incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

(d)The following exhibits are filed as a part of this Report.

 

Exhibit No.

 

Description

99.1

 

Press release announcing commencement of private placement offering.

 

2


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

TRUVEN HOLDING CORP.

 

TRUVEN HEALTH ANALYTICS INC.

(Registrant)

 

(Registrant)

 

 

 

 

 

 

By:

/s/ ANDRA K. HELLER

 

By:

/s/ ANDRA K. HELLER

Andra K. Heller, General Counsel and Secretary

 

Andra K. Heller, General Counsel and Secretary

Date: November 6, 2014

 

Date: November 6, 2014

 

EXHIBIT INDEX

 

Exhibit No.

 

Description

99.1

 

Press release announcing commencement of private placement offering.

 

3